Australia's Incannex jumps on $93 mln takeover deal

Incannex Healthcare

24/03/2022 11:33

** U.S.-listed shares of Australian medical cannabinoid co
Incannex Healthcare Ltd  IXHL.O  were up 17.15% at $13.80
premarket 
    ** Co after market close on Wednesday proposed to buy
Netherlands-based biopharma co APIRx Pharmaceuticals USA LLC in
an all-stock deal valued at about $93 mln [Full Story https://apac1-apps.platform.refinitiv.com/web/Apps/AdvFilings/#/view/66728605/default/docId
]
    ** APIRx will be entitled to nominate one board member to
Incannex
    ** IXHL down 21% since its Nasdaq debut earlier this month

 (Reporting by Reshma Rockie George)
 ((Reshma.George@thomsonreuters.com))